Nkinda L, et al. - In this cross-sectional study involving 240 patients in Tanzania, researchers evaluated a cohort of people living with HIV (PLHIV) for C-reactive protein (CRP) and Interleukin 6 (IL-6) levels and their connections with dysglycemia. Data reported that the dysglycemia prevalence among the sampled PLHIV population on antiretroviral therapy was 32%. High CRP correlated with a 2.05 greater odds of having dysglycemia, while taking stavudine correlated with a 1.99 odds of having dysglycemia. No significant association was seen between IL-6 and dysglycemia. Among PLHIV with undetectable viral load, high CRP was significantly linked to dysglycemia. Taking stavudine has been related to increased odds of dysglycemia.